Blinktbi, Inc

Blinktbi, Inc is a health tech startup with the mission to provide "Objective data in the blink of an eye." Their FDA-cleared technology, EyeStat™, enables the delivery of objective data about the blink reflex in just minutes using light puffs of air and high-speed videography. The company's foundational research and proof of concept data supports EyeStat's initial application, which is intended to test for and identify abnormal blink patterns associated with traumatic brain injury (TBI). In addition to TBI, Blinktbi is exploring applications in the diagnosis, differentiation, and management of neurological diseases and conditions such as Parkinson's, Alzheimer's, and Migraine. Founded in 2017 and headquartered in the United States, Blinktbi, Inc focuses on the industries of Health Care, Health and Wellness, and Medical Devices. The company is gaining traction in the field of central nervous system (CNS) research, as evidenced by the related initiatives found on their sister account, blinkcns. With no publicly available information on their last investment, Blinktbi, Inc presents an intriguing opportunity for potential investors to consider in the burgeoning health tech sector.